Tim Morris, director of animal ethics at drugs giant GlaxoSmithKline, said his company was committed to the UK in the long term after spending £1.1bn on research here but warned of 'the corrosive effect of animal rights extremists which leads to potential for lost opportunities - for example future investment'.